Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析

◆英語タイトル:Amarin Corp Plc (AMRN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH58486FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥33,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥49,875見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Amarin Corp Plc (AMRN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Amarin Corp Plc (Amarin) is a pharmaceutical company which develops and commercializes medicines for cardiovascular diseases. The company’s lead product, Vascepa (icosapent ethyl), is a single-molecule prescription capsule used as an adjunct to diet for the reduction of triglyceride levels in adult patients with severe hypertriglyceridemia and high triglyceride levels or mixed dyslipidemia andcardiovascular risk. The company is also evaluating Vascepa as an add-on therapy to reduce major cardiovascular events in an at-risk patient population on statin therapy. Amarin markets the product in the US through wholesalers and specialty pharmacy providers. The company has operations in Ireland, the US, Germany, Switzerland, the Uk, Italy, France and Israel. Amarin is headquartered at Dublin, Ireland.

Amarin Corp Plc Key Recent Developments

Feb 25,2021: Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 17,2021: Amarin to Report Fourth Quarter and Full Year 2020 Results and Host Conference Call on February 25, 2021
Jan 07,2021: Amarin provides preliminary 2020 results and 2021 outlook
Nov 30,2020: Amarin files patent infringement lawsuit against Hikma
Nov 05,2020: Amarin reports third quarter 2020 financial results and provides business update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Amarin Corp Plc – Key Facts
Amarin Corp Plc – Key Employees
Amarin Corp Plc – Key Employee Biographies
Amarin Corp Plc – Major Products and Services
Amarin Corp Plc – History
Amarin Corp Plc – Company Statement
Amarin Corp Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Amarin Corp Plc – Business Description
Product Category: Licensing Revenue
Overview
Performance
Product Category: Vascepa
Overview
Performance
R&D Overview
Amarin Corp Plc – SWOT Analysis
SWOT Analysis – Overview
Amarin Corp Plc – Strengths
Amarin Corp Plc – Weaknesses
Amarin Corp Plc – Opportunities
Amarin Corp Plc – Threats
Amarin Corp Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amarin Corp Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 25, 2021: Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 17, 2021: Amarin to Report Fourth Quarter and Full Year 2020 Results and Host Conference Call on February 25, 2021
Jan 07, 2021: Amarin provides preliminary 2020 results and 2021 outlook
Nov 30, 2020: Amarin files patent infringement lawsuit against Hikma
Nov 05, 2020: Amarin reports third quarter 2020 financial results and provides business update
Aug 04, 2020: Amarin reports second quarter 2020 financial results and provides update on operations
Apr 30, 2020: Amarin reports first quarter 2020 financial results and provides update on operations
Apr 28, 2020: Amarin to Report First Quarter 2020 Results and Host Conference Call on April 30, 2020
Feb 25, 2020: Amarin reports record fourth quarter and full year 2019 financial results and provides update on operations
Jan 13, 2020: Amarin launches true to your heart, a campaign to educate people on persistent cardiovascular risk
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Amarin Corp Plc, Key Facts
Amarin Corp Plc, Key Employees
Amarin Corp Plc, Key Employee Biographies
Amarin Corp Plc, Major Products and Services
Amarin Corp Plc, History
Amarin Corp Plc, Subsidiaries
Amarin Corp Plc, Key Competitors
Amarin Corp Plc, Ratios based on current share price
Amarin Corp Plc, Annual Ratios
Amarin Corp Plc, Annual Ratios (Cont...1)
Amarin Corp Plc, Interim Ratios
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Amarin Corp Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Amarin Corp Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Amarin Corp Plc (AMRN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Hwa Tai Industries Berhad:企業の戦略・SWOT・財務分析
    Hwa Tai Industries Berhad - Strategy, SWOT and Corporate Finance Report Summary Hwa Tai Industries Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sartorius Stedim Biotech SA (DIM)-医療機器分野:企業M&A・提携分析
    Summary Sartorius Stedim Biotech SA (SSB) is a supplier of equipment and services to the biopharmaceutical companies. It offers integrated solutions covering filtration, fermentation, fluid management, purification and lab technologies. Its major products include laboratory balances, OEM weigh cells …
  • Wellcome Trust Sanger Institute-医療機器分野:企業M&A・提携分析
    Summary Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research …
  • WestRock Co:戦略・SWOT・企業財務分析
    WestRock Co - Strategy, SWOT and Corporate Finance Report Summary WestRock Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Fresenius Kabi AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Fresenius Kabi AG (Fresenius Kabi), a wholly owned subsidiary of Fresenius SE & Co KGaA, develops, manufactures and markets pharmaceuticals products and medical devices. The company's product portfolio includes intravenously administered drugs, infusion therapy products, medical devices and …
  • RattanIndia Power Ltd (RTNPOWER):電力:M&Aディール及び事業提携情報
    Summary RattanIndia Power Ltd (RattanIndia Power), formerly Sophia Power Company Ltd is a power company that constructs, develops, operates, and manages thermal power projects across India. The company offers renewable energy solutions, operation and management of power plants, and project managemen …
  • Admiral Taverns Ltd.:企業の戦略・SWOT・財務情報
    Admiral Taverns Ltd. - Strategy, SWOT and Corporate Finance Report Summary Admiral Taverns Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • JFE Holdings, Inc.:企業の戦略・SWOT・財務情報
    JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary JFE Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Multiplicom NV-医療機器分野:企業M&A・提携分析
    Summary Multiplicom NV (Multiplicom) is a molecular diagnostic company that develops, manufactures and markets genetic test kits. The company offers onco genetics, human genetics and prenatal genetics products. Its human genetics products are used for cancer genetics, genetic disorders and neurologi …
  • Sanofi India Ltd (SANOFI):企業の財務・戦略的SWOT分析
    Summary Sanofi India Ltd (Sanofi India), formerly Aventis Pharma Ltd, a subsidiary of Sanofi is a healthcare company. It manufactures and markets pharmaceutical and prescription products. The company offers products in the form of capsules, tablets, injection, vials, ampoules, ointments, creams and …
  • Gardner Denver Holdings, Inc. (GDI):企業の財務・戦略的SWOT分析
    Gardner Denver Holdings, Inc. (GDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Roper Technologies Inc (ROP):企業の財務・戦略的SWOT分析
    Roper Technologies Inc (ROP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ivoclar Vivadent AG:医療機器:M&Aディール及び事業提携情報
    Summary Ivoclar Vivadent AG (Ivoclar Vivadent) is an international dental products providing company. It manufactures material systems for high quality dental applications. The company’s products include impression materials, adhesives, temporary materials, restorative materials, all-ceramics, lutin …
  • Fuji Seal International Inc.:戦略・SWOT・企業財務分析
    Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report Summary Fuji Seal International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • EnerNOC, Inc.-エネルギー分野:企業M&A・提携分析
    Summary EnerNOC, Inc. (EnerNOC), formerly EnerNOC, LLC, is a provider of energy intelligence software (EIS) and demand response solutions. The company’s EIS offers enterprise customers with Software-as-a-Service (SaaS) solutions with various areas of functionalities. It offers SaaS solutions to mana …
  • HDI-Global SE:企業の戦略・SWOT・財務分析
    HDI-Global SE - Strategy, SWOT and Corporate Finance Report Summary HDI-Global SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Purdue Pharma LP-製薬・医療分野:企業M&A・提携分析
    Summary Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) med …
  • Oil Search Ltd (OSH):石油・ガス:M&Aディール及び事業提携情報
    Summary Oil Search Ltd (Oil Search) is an independent upstream energy company. It explores for, develops and produces oil, natural gas and natural gas liquids (NGL). The company has majority of its oil and gas assets in Papua New Guinea (PNG) and operates all the producing oil fields in the country. …
  • Sv. Sv. Konstantin I Elena Holding Ad
    Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report Summary Sv. Sv. Konstantin I Elena Holding Ad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • MIE Holdings Corp (1555):石油・ガス:M&Aディール及び事業提携情報
    Summary MIE Holdings Corp (MIEH), a subsidiary of Far East Energy Ltd is an oil and gas company that carries out exploration, development and production activities. The company operates Daan, Moliqing and Miao 3 oilfields in the Songliao Basin. Its Daan oilfield is located in Daan City that covers a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆